These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32659173)

  • 1. Tacrolimus dose modification in patients receiving concomitant isavuconazole after hematopoietic stem cell transplantation.
    Trifilio S; Rubin H; Monacelli A; Mehta J
    J Oncol Pharm Pract; 2021 Jun; 27(4):857-862. PubMed ID: 32659173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Drug Interaction Between Isavuconazole and Tacrolimus: Is Empiric Dose Adjustment Necessary?
    Kufel WD; Armistead PM; Daniels LM; Ptachcinski JR; Alexander MD; Shaw JR
    J Pharm Pract; 2020 Apr; 33(2):226-230. PubMed ID: 30049245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once-daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation.
    Mimura A; Yamaori S; Ikemura N; Katsuyama Y; Matsuzawa N; Ohmori S
    J Clin Pharm Ther; 2019 Aug; 44(4):565-571. PubMed ID: 30950099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug-drug interaction study.
    Kieu V; Jhangiani K; Dadwal S; Nakamura R; Pon D
    Transpl Infect Dis; 2019 Feb; 21(1):e13007. PubMed ID: 30295407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients.
    Rivosecchi RM; Clancy CJ; Shields RK; Ensor CR; Shullo MA; Falcione BA; Venkataramanan R; Nguyen MH
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of initiating posaconazole on tacrolimus pharmacokinetics in allogeneic stem cell transplantation.
    Collins J; Shea K; Parsad S; Plach K; Lee P
    J Oncol Pharm Pract; 2020 Jan; 26(1):5-12. PubMed ID: 30854922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation.
    Butts AR; Brown VT; McBride LD; Bolaños-Meade J; Bryk AW
    J Oncol Pharm Pract; 2016 Apr; 22(2):275-83. PubMed ID: 25802301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
    Maertens JA; Raad II; Marr KA; Patterson TF; Kontoyiannis DP; Cornely OA; Bow EJ; Rahav G; Neofytos D; Aoun M; Baddley JW; Giladi M; Heinz WJ; Herbrecht R; Hope W; Karthaus M; Lee DG; Lortholary O; Morrison VA; Oren I; Selleslag D; Shoham S; Thompson GR; Lee M; Maher RM; Schmitt-Hoffmann AH; Zeiher B; Ullmann AJ
    Lancet; 2016 Feb; 387(10020):760-9. PubMed ID: 26684607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
    Peksa GD; Schultz K; Fung HC
    J Oncol Pharm Pract; 2015 Dec; 21(6):409-15. PubMed ID: 24938293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.
    Nara M; Takahashi N; Miura M; Niioka T; Kagaya H; Fujishima N; Saitoh H; Kameoka Y; Tagawa H; Hirokawa M; Sawada K
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1321-9. PubMed ID: 23354810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation.
    Mori T; Kato J; Yamane A; Sakurai M; Kohashi S; Kikuchi T; Ono Y; Okamoto S
    Int J Hematol; 2012 May; 95(5):564-9. PubMed ID: 22461034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus clearance is age-dependent within the pediatric population.
    Przepiorka D; Blamble D; Hilsenbeck S; Danielson M; Krance R; Chan KW
    Bone Marrow Transplant; 2000 Sep; 26(6):601-5. PubMed ID: 11041564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.
    Yamashita T; Fujishima N; Miura M; Niioka T; Abumiya M; Shinohara Y; Ubukawa K; Nara M; Fujishima M; Kameoka Y; Tagawa H; Hirokawa M; Takahashi N
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):111-8. PubMed ID: 27217047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults.
    Groll AH; Desai A; Han D; Howieson C; Kato K; Akhtar S; Kowalski D; Lademacher C; Lewis W; Pearlman H; Mandarino D; Yamazaki T; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):76-85. PubMed ID: 27273343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.
    Spriet I; Grootaert V; Meyfroidt G; Debaveye Y; Willems L
    Eur J Clin Pharmacol; 2013 Mar; 69(3):737-8. PubMed ID: 22878691
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations.
    Gu TM; Lewis JS; Le H; Bubalo JS
    J Oncol Pharm Pract; 2022 Sep; 28(6):1357-1362. PubMed ID: 34192963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation.
    Yano S; Mori S; Saito T; Yokoyama H; Machishima T; Shimada T; Yahagi Y; Sugiyama K; Ogasawara Y; Takahara S; Kasama K; Katsube A; Kamiyama Y; Suzuki K; Inui Y; Usui N; Aiba K; Yamashita T
    Ann Hematol; 2015 Mar; 94(3):491-6. PubMed ID: 25325985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring.
    Trifilio SM; Scheetz MH; Pi J; Mehta J
    Bone Marrow Transplant; 2010 Aug; 45(8):1352-6. PubMed ID: 19966844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case Series and Literature Review of Isavuconazole Use in Pediatric Patients with Hemato-oncologic Diseases and Hematopoietic Stem Cell Transplantation.
    Decembrino N; Perruccio K; Zecca M; Colombini A; Calore E; Muggeo P; Soncini E; Comelli A; Molinaro M; Goffredo BM; De Gregori S; Giardini I; Scudeller L; Cesaro S
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.